Ethnicity and schizophrenia medication choice: Haloperidol, risperidone, or olanzapine

被引:0
|
作者
Opolka, JL
Rascati, KL
Brown, CM
Gibson, PJ
机构
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] Univ Texas, Austin, TX 78712 USA
关键词
D O I
10.1016/S1098-3015(10)64212-X
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:345 / 345
页数:1
相关论文
共 50 条
  • [1] Ethnicity and schizophrenia medication choice: haloperidol risperidone, or olanzapine.
    Opolka, JL
    Rascati, KL
    Brown, CM
    Gibson, PJ
    [J]. PHARMACOTHERAPY, 2003, 23 (03): : 412 - 412
  • [2] Ethnicity and prescription patterns for haloperidol, risperidone, and olanzapine
    Opolka, JL
    Rascati, KL
    Brown, CM
    Gibson, PJ
    [J]. PSYCHIATRIC SERVICES, 2004, 55 (02) : 151 - 156
  • [3] Clozapine, olanzapine, risperidone, and haloperidol in refractory schizophrenia
    Mohr, P
    Volavka, J
    Lieberman, JA
    Czobor, P
    McEvoy, J
    Lindenmayer, JP
    Citrome, L
    Sheitman, B
    [J]. EUROPEAN PSYCHIATRY, 2000, 15 : 284S - 284S
  • [4] Olanzapine versus risperidone and haloperidol in treatment of schizophrenia
    Jones, B
    Tollefson, G
    [J]. SCHIZOPHRENIA RESEARCH, 1998, 29 (1-2) : 150 - 151
  • [5] Olanzapine, risperidone and haloperidol in the treatment of adolescent patients with schizophrenia
    D. Gothelf
    A. Apter
    J. Reidman
    A. Brand-Gothelf
    Y. Bloch
    G. Gal
    L. Kikinzon
    S. Tyano
    R. Weizman
    G. Ratzoni
    [J]. Journal of Neural Transmission, 2003, 110 : 545 - 560
  • [6] Olanzapine, risperidone and haloperidol in the treatment of adolescent patients with schizophrenia
    Gothelf, D
    Apter, A
    Reidman, J
    Brand-Gothelf, A
    Bloch, Y
    Gal, G
    Kikinzon, L
    Tyano, S
    Weizman, R
    Ratzoni, G
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2003, 110 (05) : 545 - 560
  • [7] Prolactin response in patients with schizophrenia treated with haloperidol, clozapine, risperidone and olanzapine
    Potkonjak, Jelena
    Karlovic, Dalibor
    Bukovec, Zeljka
    Baricevic, Tihana
    [J]. BIOCHEMIA MEDICA, 2009, 19 (01) : 73 - 80
  • [8] The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia
    David, SR
    Taylor, CC
    Kinon, BJ
    Breier, A
    [J]. CLINICAL THERAPEUTICS, 2000, 22 (09) : 1085 - 1096
  • [9] The impact of olanzapine, risperidone, or haloperidol on the cost of schizophrenia care in a Medicaid population
    Gibson, PJ
    Damler, R
    Jackson, EA
    Wilder, T
    Ramsey, JL
    [J]. VALUE IN HEALTH, 2004, 7 (01) : 22 - 35
  • [10] Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia
    Citrome, L
    Volavka, J
    Czobor, P
    Sheitman, B
    Lindenmayer, JP
    McEvoy, J
    Cooper, TB
    Chakos, M
    Lieberman, JA
    [J]. PSYCHIATRIC SERVICES, 2001, 52 (11) : 1510 - 1514